01 Nov
|
CA04 (FCRS = CA004) NOVARTIS PHARMA CANADA
|
Toronto
01 Nov
CA04 (FCRS = CA004) NOVARTIS PHARMA CANADA
Toronto
Job Description Summary
Job Description Summary #LI-Hybrid Location: Toronto, Ontario Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you. This job posting is for an existing position Implement country-level health economics, pricing and reimbursement strategies to support timely listings and contract renewals for Novartis brands. Translate payer research into actionable insights, shape evidence-based pricing and market positioning, and lead cross-functional development of high-quality HTA and pricing and reimbursement submissions. Develop impactful product listing agreements and negotiation strategies in collaboration with Health Policy, Access, Medical and international HEOR partners.
Key Responsibilities
- Lead the development of optimal brand pricing strategies in collaboration with Global and Regional Pricing and Reimbursement teams and Brand Directors or Managers.
- Develop robust economic evidence and transparent value messages to support timely listing and optimal national patient access for Novartis brands.
- Lead HTA submissions for assigned assets, working with cross-functional partners to support the overall Access strategy.
- Interpret payer research and the Canadian reimbursement environment to identify opportunities, barriers and stakeholder needs for asset launches.
- Develop high-quality evidence dossiers, submission strategies, plans and deliverables for Canadian HTA and pricing and reimbursement bodies, including Canada’s Drug Agency and INESSS.
- Partner with Access, Medical, International HEOR and other internal stakeholders to define contracting strategies for new and existing products.
- Develop product listing agreements and negotiation strategies in collaboration with Health Policy and Access colleagues.
- Coordinate internal processes and external partners, including procurement, vendor engagement and HEOR approval activities, to deliver evidence-generation work efficiently.
- Report product-related technical complaints, adverse events and special-case scenarios within 24 hours of receipt, and support distribution of marketing samples where applicable.
Essential Requirements
- Relevant advanced education in health economics, epidemiology, biostatistics, outcomes research or a related discipline; strong English communication skills; and demonstrated experience in Canadian HTA and market access.
- Understanding of the Canadian HTA process, including Canada’s Drug Agency and INESSS, and the ability to assess launch opportunities and hurdles strategically.
- Expertise in at least one HTA evidence area, such as economic modelling, systematic reviews or indirect treatment comparisons.
- Experience developing or contributing to HTA strategies, evidence dossiers and submissions for pharmaceutical assets.
- Knowledge across health economics, epidemiology, biostatistics, systematic reviews and market access.
- Ability to collaborate effectively across Access, Medical,
HEOR and other cross-functional or international teams.
- Strong written and verbal communication skills, sound judgment and a willingness to learn internal processes and ways of working.
- Demonstrated action orientation, collaboration, self-awareness and ability to optimize work processes.
Rewards
- At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen.
- Expected Remuneration Range for role: CAD 121,873 – 169,188
- The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically.
- The rewards of being part of our team go far beyond base pay and incentives.
- We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs.
- In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.
- Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.
- Read our brochure to learn more about our global total rewards offering: https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf
- Note: Benefits and compensation may vary by country and are subject to local legal requirements.
-
📌 Manager, Health Economics and Outcomes Research (Toronto)
🏢 CA04 (FCRS = CA004) NOVARTIS PHARMA CANADA
📍 Toronto